Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 173 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1452
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2753-2786
Open Access | Times Cited: 1110
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 661
Obesity Management in Adults
Arielle Elmaleh-Sachs, Jessica L. Schwartz, Carolyn T. Bramante, et al.
JAMA (2023) Vol. 330, Iss. 20, pp. 2000-2000
Open Access | Times Cited: 195
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
Tamer Coşkun, Shweta Urva, William C. Roell, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1234-1247.e9
Open Access | Times Cited: 154
Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
Tiziana Fernández, Macarena Viñuela, Catalina Vidal, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263931-e0263931
Open Access | Times Cited: 69
The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes
Magdalena Wronka, Julia Krzemińska, Ewelina Młynarska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15743-15743
Open Access | Times Cited: 69
Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials
Hiddo J.L. Heerspink, Ellen M. Apperloo, Melanie J. Davies, et al.
Diabetes Care (2023) Vol. 46, Iss. 4, pp. 801-810
Open Access | Times Cited: 51
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, Javed Butler, George L. Bakris, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 2, pp. 108389-108389
Open Access | Times Cited: 39
A comprehensive review of small-molecule drugs for the treatment of type 2 diabetes mellitus: Synthetic approaches and clinical applications
Yuanyuan Guo, Jingyi Zhang, Jinfeng Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116185-116185
Closed Access | Times Cited: 14
Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials
Alaa Abdrabou Abouelmagd, Amro Mamdouh Abdelrehim, Mohamed Nabih Bashir, et al.
Baylor University Medical Center Proceedings (2025), pp. 1-13
Closed Access | Times Cited: 1
Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018
Chaojun Yang, Xiaocan Jia, Yuping Wang, et al.
BMC Geriatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 40
Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD
Thomas Marjot, Jeremy Tomlinson, Leanne Hodson, et al.
Gut (2023) Vol. 72, Iss. 8, pp. 1607-1619
Open Access | Times Cited: 37
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes
Nita G. Forouhi
Diabetologia (2023) Vol. 66, Iss. 5, pp. 786-799
Open Access | Times Cited: 35
Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
Yasmin Mesquita, Izabela Pera Calvi, Isabela Reis Marques, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 10, pp. 883-892
Closed Access | Times Cited: 29
Real‐world weight‐loss effectiveness of glucagon‐like peptide‐1 agonists among patients with type 2 diabetes: A retrospective cohort study
Gretchen E. White, Ingrid Shu, David Rometo, et al.
Obesity (2023) Vol. 31, Iss. 2, pp. 537-544
Open Access | Times Cited: 25
An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial
You‐Bin Lee, Gyuri Kim, Ji Eun Jun, et al.
Diabetes Care (2023) Vol. 46, Iss. 5, pp. 959-966
Open Access | Times Cited: 25
Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
Rasha Alhiary, Aaron S. Kesselheim, Sarah Gabriele, et al.
JAMA (2023) Vol. 330, Iss. 7, pp. 650-650
Open Access | Times Cited: 21
A 5:2 Intermittent Fasting Meal Replacement Diet and Glycemic Control for Adults With Diabetes
Lixin Guo, Yue Xi, Jin Wenbo, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2416786-e2416786
Open Access | Times Cited: 13
Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group
Andrej Janež, Emir Muzurović, Paweł Bogdański, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 9, pp. 1865-1892
Open Access | Times Cited: 11
Neurohormonal Changes in the Gut–Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery
Eirini Martinou, Irena Stefanova, Evangelia Iosif, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3339-3339
Open Access | Times Cited: 36
Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations
Ariana M. Chao, Jena Shaw Tronieri, Anastassia Amaro, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 4449-4461
Open Access | Times Cited: 36
Effect of a Comprehensive Telehealth Intervention vs Telemonitoring and Care Coordination in Patients With Persistently Poor Type 2 Diabetes Control
Matthew J. Crowley, Phillip Tarkington, Hayden B. Bosworth, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 9, pp. 943-943
Open Access | Times Cited: 35
Use of Continuous Glucose Monitors by People Without Diabetes: An Idea Whose Time Has Come?
David C. Klonoff, Kevin T. Nguyen, Nicole Y. Xu, et al.
Journal of Diabetes Science and Technology (2022) Vol. 17, Iss. 6, pp. 1686-1697
Open Access | Times Cited: 32
Impairment of Mitochondrial Respiration in Metabolic Diseases: An Overview
Vlad Florian Avram, Adrian P. Merce, Iasmina M. Hâncu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8852-8852
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top